collaboration

In the financial services industry, analysts need to switch between structured data (such as time-series pricing information), unstructured text (such as SEC filings and analyst reports), and audio/visual content (earnings calls and presentations). Each format requires different analytical approaches and specialized tools, creating workflow inefficiencies. Add on top of thisContinue Reading

Enterprises—especially in the insurance industry—face increasing challenges in processing vast amounts of unstructured data from diverse formats, including PDFs, spreadsheets, images, videos, and audio files. These might include claims document packages, crash event videos, chat transcripts, or policy documents. All contain critical information across the claims processing lifecycle. Traditional dataContinue Reading

The Amazon Bedrock multi-agent collaboration feature gives developers the flexibility to create and coordinate multiple AI agents, each specialized for specific tasks, to work together efficiently on complex business processes. This enables seamless handling of sophisticated workflows through agent cooperation. This post aims to demonstrate the application of multiple specializedContinue Reading

Today, we’re announcing the general availability (GA) of multi-agent collaboration on Amazon Bedrock. This capability allows developers to build, deploy, and manage networks of AI agents that work together to execute complex, multi-step workflows efficiently. Since its preview launch at re:Invent 2024, organizations across industries—including financial services, healthcare, supply chainContinue Reading

Large language model (LLM) based AI agents that have been specialized for specific tasks have demonstrated great problem-solving capabilities. By combining the reasoning power of multiple intelligent specialized agents, multi-agent collaboration has emerged as a powerful approach to tackle more intricate, multistep workflows. The concept of multi-agent systems isn’t entirelyContinue Reading

Sundry Photography/iStock Editorial via Getty Images Prelude Therapeutics (NASDAQ:PRLD) has forged a deal with Merck (NYSE:MRK) to test its investigational SMARCA2 degrader in combination with the latter’s blockbuster anti-PD-1 therapy, Keytruda (pembrolizumab), in patients with SMARCA4-mutated cancers. Shares of Prelude Therapeutics (PRLD) climbed as much as 28% following the news.Continue Reading

Biopharmaceutical company Innovent Biologics (OTCPK:IVBIY) and IASO Biotechnology enter agreement under which IASO will purchase Innovent’s (OTCPK:IVBIY) relevant rights of FUCASO under the original “BCMA CAR-T Cell Therapy Cooperation Agreement” at the agreed price and Innovent (OTCPK:IVBIY) will use the proceeds to acquire an 18% stake in IASO Bio. UnderContinue Reading